Intrinsic Value of S&P & Nasdaq Contact Us

Universal Health Services, Inc. UHS NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$441.48
+142.6%
Analyst Price Target
$245.67
+35%

Universal Health Services, Inc. (UHS) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $181.95. It has a SharesGrow Score of 74/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of UHS = $441.48 (+142.6% from the current price, the stock appears undervalued). Analyst consensus target is UHS = $246 (+35% upside).

Valuation: UHS trades at a trailing Price-to-Earnings (P/E) of 8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.88.

Financials: revenue is $17.4B, +9%/yr average growth. Net income is $1.5B, growing at +31.9%/yr. Net profit margin is 8.6% (thin). Gross margin is 90.4% (+1.4 pp trend).

Balance sheet: total debt is $5.5B against $7.3B equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 1.05 (adequate). Debt-to-assets is 34.5%. Total assets: $16.0B.

Analyst outlook: 18 / 43 analysts rate UHS as buy (42%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 91/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 80/100 (Pass), Future 52/100 (Partial), Income 45/100 (Partial).

$245.67
▲ 35.02% Upside
Average Price Target
Based on 43 Wall Street analysts offering 12-month price targets for Universal Health Services, Inc., the average price target is $245.67, with a high forecast of $274.00, and a low forecast of $219.00.
Highest Price Target
$274.00
Average Price Target
$245.67
Lowest Price Target
$219.00

UHS SharesGrow Score Overview

74/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 91/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 80/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — UHS

VALUE Pass
91/100
UHS trades at a trailing Price-to-Earnings (P/E) of 8 (S&P 500 average ~25). Forward PEG 0.88 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.82. Analyst consensus target is $246, implying +35.2% from the current price $182. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
83/100
UHS: +9%/yr revenue is, +31.9%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
UHS: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet UHS: Debt-to-Equity (D/E) ratio 0.76 (moderate), Current ratio is 1.05 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Pass
80/100
UHS: Gross margin is 90.4% (+1.4 pp trend), $12B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 80/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 18 / 43 analysts rate UHS as buy (42%). Analyst consensus target is $246 (+35.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
UHS: Net profit margin is 8.6%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range152.33-246.33
Volume477.3K
Avg Volume (30D)741.12K
Market Cap$11.57B
Beta (1Y)1.30
Dividend Yield$0.8000
Share Statistics
EPS (TTM)23.42
Shares Outstanding$63.58M
IPO Date1981-07-09
Employees78,400
CEOMarc D. Miller
Financial Highlights & Ratios
Revenue (TTM)$17.36B
Gross Profit$15.71B
EBITDA$2.74B
Net Income$1.49B
Operating Income$1.99B
Total Cash$137.8M
Total Debt$5.51B
Net Debt$5.37B
Total Assets$15.96B
Price / Earnings (P/E)7.8
Price / Sales (P/S)0.67
Analyst Forecast
1Y Price Target$242.00
Target High$274.00
Target Low$219.00
Upside+33.0%
Rating ConsensusHold
Analysts Covering43
Buy 42% Hold 53% Sell 5%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS9139031002

Price Chart

UHS
Universal Health Services, Inc.  ·  NYSE
Healthcare • Medical - Care Facilities
152.33 52WK RANGE 246.33
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message